$13.85
Today
as of Jul 22, 16:54 ET
Last 30 days
Recent Press Releases & News
Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer
BTIG Research Initiates Coverage on Sensei Biotherapeutics With Buy Rating, $55 Price Target
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Overview
52-week range
$5.60
$37
26% of range
Avg surprise (last 2)
-10,565%
Avg reaction (last 2)
-1.2%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-131.45 | $-0.62 | -21,102% | -48,585% | +3.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-3.62 | — | — | — | — | financials |
| Mon Jun 30, 2025 | Jun 2025 | $-3.91 | — | — | — | — | financials |
| Tue May 6, 2025 | Mar/2025 | $-0.27 | $-0.21 | -28.6% | — | -5.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-5.77 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-5.69 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.32 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.28 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.31 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-171M | — | $-5M | $-5M | $-7M | — | $-8M | $-8M |
| Net income | $-170M | — | $-5M | $-5M | $-7M | — | $-7M | $-7M |
| EPS (diluted) | $-131.45 | — | $-3.62 | $-3.91 | $-5.45 | — | $-5.77 | $-5.69 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $152M | $9M | $11M | $13M | $10M | $10M | $19M | $12M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $204M | $22M | $26M | $30M | $36M | $42M | $48M | $54M |
| Total assets | $205M | $23M | $28M | $32M | $38M | $45M | $53M | $60M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $14M | $4M | $5M | $4M | $6M | $7M | $7M | $8M |
| Total equity | $-137M | $19M | $23M | $27M | $32M | $38M | $46M | $52M |
Implied volatility — last 90 days
No IV snapshots yet for SNSE.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.